APA Alıntı

Belohlavkova, P., Vrbacky, F., Voglova, J., Racil, Z., Zackova, D., Hrochova, K., . . . Zak, P. (2018). The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Arch Med Sci.

Chicago Stili Alıntı

Belohlavkova, Petra, Filip Vrbacky, Jaroslava Voglova, Zdenek Racil, Daniela Zackova, Katerina Hrochova, Jana Malakova, Jiri Mayer, ve Pavel Zak. "The Significance of Enzyme and Transporter Polymorphisms for Imatinib Plasma Levels and Achieving an Optimal Response in Chronic Myeloid Leukemia Patients." Arch Med Sci 2018.

MLA Alıntı

Belohlavkova, Petra, et al. "The Significance of Enzyme and Transporter Polymorphisms for Imatinib Plasma Levels and Achieving an Optimal Response in Chronic Myeloid Leukemia Patients." Arch Med Sci 2018.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..